Senescent Cells Are Essential for Building the Brain’s Barriers

Summary: A new study revealed that senescent cells, traditionally vilified as inflammatory “zombie cells” that drive aging and cognitive decline, are actually critical architects of the developing brain. The research demonstrates that these non-dividing cells appear at precise developmental windows to orchestrate the construction of the body’s most vital security systems: the blood-brain barrier (BBB) and the blood-cerebrospinal fluid (CSF) barrier.

Utilizing single-cell RNA sequencing, genetic lineage tracing, and advanced imaging in mouse embryos, the team isolated three distinct cell types that temporarily shift into a senescent state to coordinate vascular patterning, fluid balance, and structural integrity. Crucially, while most developmental senescence is strictly temporary, researchers made the shocking discovery that epithelial cells in the choroid plexus retain their senescent features all the way into adulthood, proving that cellular senescence is not a uniform engine of decay, but a highly specialized, context-dependent tool of life.

Key Facts

  • The Ultimate Paradigm Shift: Cellular senescence, long considered a purely destructive, irreversible marker of advanced aging and neurodegenerative pathology, has been proven essential for normal embryonic brain development.
  • Brain Barrier Architects: The research establishes that without the presence of these specialized senescent cells during gestation, embryos develop severe abnormalities in brain-barrier structural formation and intracranial fluid balance.
  • Three “Zombie” Specialists: Using high-resolution single-cell sequencing, investigators caught three distinct cell types entering a senescent state to construct brain defenses: vascular endothelial cells, brain-resident macrophages, and choroid plexus epithelial cells.
  • The Permanent adult Exception: While endothelial and macrophage senescence is highly transient (disappearing after blood vessels are patterned), choroid plexus epithelial cells stubbornly maintain their senescent signature well into adulthood.
  • Coordinated Cellular Teams: Rather than acting as isolated, dying units, senescent cells function as signaling hubs, communicating across different cell types to meticulously weave together the brain’s protective vascular and epithelial barriers.
  • New Disease Horizon: By proving that senescence takes completely different molecular shapes depending on the cell type and developmental timing, the team has opened up a new avenue to study how these identical pathways might go haywire in adult brain diseases.

Source: UCSD

Among the body’s most crucial protective features are the brain barrier systems, including the blood-brain and blood-cerebrospinal fluid (CSF) barriers.

These barriers are made of highly specialized cells that allow essential nutrients to enter, yet repel dangerous toxins and pathogens that may be circulating in the bloodstream. Scientists have long known what these barriers do, but less about how they are built during development.

This shows a mouse fetus and a brain.
Researchers found that three cell types enter a senescent state during development: vascular endothelial cells (red), brain-resident macrophages (green) and choroid plexus epithelial cells (yellow). Credit: Ella Maru Studio, conceptualized by Ashley Watson and Hiruy Meharena

A new study led by University of California San Diego researchers and published in Cell has uncovered a key contributor: senescent cells. Often associated with aging and disease, these cells instead appear to help construct and support the brain’s protective barriers during development.

Central to their new insights is an evolving understanding of senescent cells, which traditionally have been labelled as “zombie” cells since they no longer are able to divide, yet don’t fully die off. Senescent cells accumulate with age and have been linked to tissue dysfunction, chronic inflammation and cognitive decline, making them an attractive target for therapies aimed at slowing age-related decline.

In recent years, however, new studies have shown that senescent cells are not strictly tied to aging and disease. Researchers identified senescent cells that appear temporarily in developing mouse embryos and play roles in limb and kidney development.

Other studies found that senescent cells have a transient role in wound healing, suggesting that these cells can be beneficial in some contexts. This led to the idea that senescence can be helpful when it is temporary, but harmful when it persists.

Research from the laboratory of School of Biological Sciences Assistant Professor Hiruy Meharena indicates that senescent cells play previously unrecognized roles in brain development.

Studying the developing brains of mice, Associate Project Scientist Ashley Watson identified senescent cells that emerge at distinct stages during the formation of two critical brain barrier systems: the blood-brain and blood-CSF barriers.

“We found that these senescence-associated states appear in very specialized barrier cell types and at precise moments during brain development, suggesting they may play specialized roles in building the brain’s protective barriers,” said Watson, the study’s first author.

The researchers used an array of methods during the study, including single-cell RNA sequencing, imaging and genetic lineage tracing. They found that three cell types enter a senescent state during development: vascular endothelial cells, brain-resident macrophages and choroid plexus epithelial cells.

These cells contribute to the formation of the brain’s protective barriers in different ways. In endothelial cells and macrophages, senescence appears to help coordinate blood vessel patterning and formation of the blood-brain barrier. In the choroid plexus, which produces CSF and forms the blood-CSF barrier, senescence appears to support barrier development and function.

Senescent vascular endothelial cells and brain-resident macrophages appeared only transiently during growth and remodeling of the embryonic blood vessels that form the blood-brain barrier, they found. Choroid plexus epithelial cells, in contrast, retained features of senescence long after development and remained present into adulthood.

“That was one of the most unexpected findings,” said Meharena.  “Developmental senescence has generally been viewed as a transient process. Here, we identified a population of cells in the brain that appears to maintain senescence-associated features well into adulthood. This study shows that senescence can take many different forms in the brain, depending on the cell type and stage of development.”

To test whether these cells were functionally important, the researchers eliminated senescent cells during embryonic development. Mouse embryos lacking these cells developed abnormalities in brain-barrier formation and fluid balance, indicating that senescence-associated cells contribute to normal brain development.

“What surprised us most was that senescence wasn’t a single state. It looked very different across cell types and appeared to serve distinct functions depending on where and when it occurred,” said Watson. “Moreover, the cells weren’t acting independently. Senescence seemed to help different cell types work together to build, and in some cases sustain, the brain’s protective barriers.”  

The researchers are now studying how senescence and related processes unfold in brain diseases.

Key Questions Answered:

Q: If senescent cells are needed to build the brain, why are scientists trying to kill them with “senolytic” anti-aging drugs?

A: The crucial distinction here is timing and persistence. When senescence occurs transiently during development, these cells act as highly coordinated signaling centers that guide tissue growth before gracefully exiting or being cleared out. However, when senescent cells accumulate pathologically in old age, they fail to clear, causing chronic inflammation (the senescence-associated secretory phenotype, or SASP) that degrades surrounding healthy tissue. Anti-aging therapies specifically target these toxic, lingering adult cells, not the beneficial, tightly controlled embryonic variants.

Q: How did the researchers prove that these “zombie” cells were actually required for a healthy brain?

A: The UC San Diego team used elegant genetic models to selectively target and eliminate senescent cells during the embryonic development of mice. When these cells were cleared out during gestation, the embryos developed profound structural defects, specifically showing chaotic, malformed blood vessels along the blood-brain barrier and severe fluid accumulation and pressure imbalances in the choroid plexus, demonstrating that these cells are functional necessities, not passive bystanders.

Q: What makes the discovery of lifelong senescence in the choroid plexus so shocking to neuroscientists?

A: Up until this Cell paper, developmental senescence was universally categorized as a strictly temporary, “blink-and-you-miss-it” biological scaffold—showing up to build an organ or limb and then vanishing forever. Finding a large population of choroid plexus cells that proudly maintain their senescent signature all the way from the womb into a healthy adult lifespan completely rewrites the biological definition of senescence, proving that a cell can remain in this non-dividing state indefinitely to support active organ function.

Editorial Notes:

  • This article was edited by a Neuroscience News editor.
  • Journal paper reviewed in full.
  • Additional context added by our staff.

About this neuroscience research news

Author: Mario Aguilera
Source: UCSD
Contact: Mario Aguilera – UCSD
Image: The image is credited to Ella Maru Studio, conceptualized by Ashley Watson and Hiruy Meharena

Original Research: Open access.
Persistent and transient senescent cells contribute to brain barrier development” by L. Ashley Watson, Zoe Adelsheim, Mackenzie J. Carter, Grace T. Carter, Karen L. Jimenez-Reyes, Huijie Du, Ziqing Zhu, David B. Berry, Mia C. Paredez, Rania H. Palaniappan, John M. Augustine, and Hiruy S. Meharena. Cell
DOI:10.1016/j.cell.2026.05.022


Abstract

Persistent and transient senescent cells contribute to brain barrier development

Establishment of the blood-brain barrier (BBB) and blood-cerebrospinal fluid (CSF) barrier requires precise coordination between diverse cell types to protect and nourish the brain.

Here, we identify developmentally programmed p21+ senescent cells that exhibit divergent senescence-associated features across these two brain interfaces in mice. In the choroid plexus (ChP), epithelial cells adopt a lifelong, non-inflammatory senescent state associated with CSF production and blood-CSF barrier integrity.

In contrast, vascular endothelial cells and brain-resident macrophages transiently exhibit pro-inflammatory senescence profiles during brain vascularization, with reciprocal signaling linked to angiogenic patterning and extracellular matrix assembly.

The ablation of p21+ cells during mid-gestation disrupts brain vascular patterning and ChP integrity, which results in hemorrhage, impaired CSF production, and ventricular collapse.

These findings indicate that embryonic senescent cells adopt divergent transient and long-lived states that support brain-barrier formation and homeostasis, thus reframing the prevailing view of persistent senescence beyond solely a pathological state.

Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.